Literature DB >> 2790835

Primary intracranial neoplasms in the first year of life.

A Asai1, H J Hoffman, E B Hendrick, R P Humphreys, L E Becker.   

Abstract

Forty-one infants with histologically verified primary intracranial neoplasms were studied who had been diagnosed and treated during the first year of life at the Hospital for Sick Children during the years 1975-1986. Forty-one percent of tumors were astrocytomas, 22% were primitive neuroectodermal tumors, and 20% were choroid plexus papillomas. Seventy-one percent were located in the supratentorial compartment and 29% in the infratentorial compartment. Thirty percent were in the cerebral hemisphere, 12% in the optic pathway-hypothalamic region, 5% in the thalamus, 17% in the cerebellum, 5% in the brain stem, 12% in the lateral ventricles, 12% in the III ventricle, and 7% in the IV ventricle. The most common presenting features in this series of patients were vomiting and increasing head size. The symptoms and signs before diagnosis were present for 2 months or less in 87% of cases. Forty-four percent of the tumors were totally resected while only a partial resection or biopsy was carried out in 56%. Sixty-six percent of the patients required a CSF diversionary shunt. Twenty-nine percent of patients received radiotherapy. Slightly more than half of these received radiotherapy immediately after surgery, whereas delayed radiation therapy was performed in the remainder. The surgical mortality was 7.3%. Of the entire group, 39% have died, with most dying within 6 months of surgery. Treatment, survival relative to histologic type, psychomotor development, and neurologic function of the survivors are discussed.

Entities:  

Mesh:

Year:  1989        PMID: 2790835     DOI: 10.1007/bf00271024

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  20 in total

1.  Cerebral tumors in infancy. 66 clinicoanatomical case studies.

Authors:  C Fessard
Journal:  Am J Dis Child       Date:  1968-03

2.  Medulloblastoma of the neonatal period and early infancy. Report of two cases.

Authors:  N Papadakis; J Millan; D F Grady; L H Segerberg
Journal:  J Neurosurg       Date:  1971-01       Impact factor: 5.115

3.  Quality of long-term survival following irradiation for intracranial tumors in children under the age of two.

Authors:  J J Spunberg; C H Chang; M Goldman; E Auricchio; J J Bell
Journal:  Int J Radiat Oncol Biol Phys       Date:  1981-06       Impact factor: 7.038

4.  Brain tumors presenting as a seizure disorder in infants.

Authors:  S L Rutledge; O C Snead; R Morawetz; B Chandra-Sekar
Journal:  J Child Neurol       Date:  1987-07       Impact factor: 1.987

5.  Observations on the current treatment of low-grade astrocytic tumors of the cerebral hemispheres.

Authors:  J M Piepmeier
Journal:  J Neurosurg       Date:  1987-08       Impact factor: 5.115

6.  Primitive neuroectodermal tumors of the central nervous system in children.

Authors:  E J Kosnik; C P Boesel; J Bay; M P Sayers
Journal:  J Neurosurg       Date:  1978-05       Impact factor: 5.115

7.  Brain tumors in childhood.

Authors:  A J Yates; L E Becker; L A Sachs
Journal:  Childs Brain       Date:  1979

8.  Long-term effects of cranial irradiation on endocrine function in children with brain tumors. A prospective study.

Authors:  P K Duffner; M E Cohen; M L Voorhess; M H MacGillivray; M L Brecher; A Panahon; B B Gilani
Journal:  Cancer       Date:  1985-11-01       Impact factor: 6.860

9.  Brain tumors of early infants.

Authors:  O Sato; A Tamura; K Sano
Journal:  Childs Brain       Date:  1975

10.  Intracranial tumours in the first year of life.

Authors:  R Jooma; B E Kendall
Journal:  Neuroradiology       Date:  1982       Impact factor: 2.804

View more
  16 in total

Review 1.  Toward a cure for infants with brain tumours: the challenge for the 1990's.

Authors:  P M Zeltzer
Journal:  Br J Cancer Suppl       Date:  1992-08

2.  Intra-axial endophytic primitive neuroectodermal tumors in the pons: clinical, radiological, and immunohistochemical aspects in four children.

Authors:  J Behnke; K Mursch; W Brück; H J Christen; E Markakis
Journal:  Childs Nerv Syst       Date:  1996-03       Impact factor: 1.475

3.  Choroid plexus tumor epidemiology and outcomes: implications for surgical and radiotherapeutic management.

Authors:  Donald M Cannon; Pranshu Mohindra; Vinai Gondi; Tim J Kruser; Kevin R Kozak
Journal:  J Neurooncol       Date:  2014-10-01       Impact factor: 4.130

4.  Supratentorial primitive neuroectodermal tumors in children.

Authors:  P B Dirks; L Harris; H J Hoffman; R P Humphreys; J M Drake; J T Rutka
Journal:  J Neurooncol       Date:  1996-07       Impact factor: 4.130

5.  Supratentorial cystic hemangioblastoma with infratentorial extension--a unique location and a rare infant case.

Authors:  Ismail H Tekkök; Aydin Sav
Journal:  Childs Nerv Syst       Date:  2006-03-14       Impact factor: 1.475

6.  Supratentorial tumours in infants.

Authors:  M K Tewari; B S Sharma; R K Mahajan; V K Khosla; S N Mathuriya; A Pathak; V K Kak
Journal:  Childs Nerv Syst       Date:  1994-04       Impact factor: 1.475

7.  Supratentorial ependymomas in childhood: clinicopathological findings and prognosis.

Authors:  R I Ernestus; O Wilcke; R Schröder
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

Review 8.  Surgical indication and technical considerations in the management of benign brain stem gliomas.

Authors:  S Constantini; F Epstein
Journal:  J Neurooncol       Date:  1996 May-Jun       Impact factor: 4.130

Review 9.  Treatment of infants with malignant gliomas: the Pediatric Oncology Group experience.

Authors:  P K Duffner; J P Krischer; P C Burger; M E Cohen; J W Backstrom; M E Horowitz; R A Sanford; H S Friedman; L E Kun
Journal:  J Neurooncol       Date:  1996 May-Jun       Impact factor: 4.130

10.  Central nervous system tumors in Mexican children.

Authors:  L De la Torre Mondragón; C Ridaura Sanz; M Reyes Mujica; F Rueda Franco
Journal:  Childs Nerv Syst       Date:  1993-08       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.